Abu Sadiq
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Abu Sadiq has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Magnus Felix
Department of Surgery, Chivar Specialist Hospital and Urology Center Limited, Abuja, Nigeria
2 shared publications Obiatuegwu Kenenna
Division of Urology, Department of Surgery, Federal Medical Center Abuja, Abuja, Nigeria; Department of Surgery, Baze University Abuja, Abuja, Nigeria
2 shared publications- Otabor Christopher
Department of Surgery, Alliance Hospital and Services Limited Abuja, Abuja, Nigeria
2 shared publications - Terkaa Atim
Department of Surgery, University of Abuja Teaching Hospital Gwagwalada, Abuja, Nigeria
2 shared publications Amu Okwudili
College of Medicine, University of Nigeria, Enugu Campus, Nigeria
1 shared publication
Latest Publications
- Open Access
- 16 January 2025
- Published by Science Publishing Group in International Journal of Clinical Urology
- Vol. 9 (1) , 101-106
Premature Ejaculation: Prevalence and Relationship with Body Mass Index
Introduction: Premature ejaculation is one of the major disorders of sexual functions in males. The prevalence rate of 25-40% has been reported across all age groups globally. Ejaculation latency is affected by psychosomatic factors which may include obesity but the relationship between PE and obesity have not been well documented in sub-Saharan Africa. This study evaluates the prevalence of PE and correlation between PE and body mass index. Methods: This is a prospective cross-sectional study carried out in Federal Capital Territory (FCT) Abuja, Nigeria over a period of 2 years from January 2019 to December 2020. By simple random sampling, participants were recruited for the study. Two questionnaires (a proforma and PEDT) were administered to all the participants who gave consent to be enrolled and met the inclusion criteria. Two basic anthropometric measurements (weight and height) were objectively obtained. Data obtained were analyzed using Statistical Package for Social Sciences version 20.0. P value of less than 0.05 was considered statistically significant. Results: A total of 426 persons participated in the study. Majority of the participants (51.88%) fell within the age range of 20-30 years, while seventy-five participants (17.61%) were between the age ranges of 31-40 years. Those that fell within the age range of 41-50, 51-60, and 61-70 years were 16.43%, 8.22% and 5.87% respectively. Seventy-two participants (16.9%) had PE while three hundred and six participants (71.83%) had no PE. Probable/borderline PE was noted in 48 (11.27%) participants. Mean age of participants with PE was 27.88 years while the mean age of participants with borderline PE was 25.67 years. Mean age of participants with no PE was 41.85 years. Sixty-seven participants (15.73%) were obese, 131 (30.75%) were overweight while 228 (53.52%) had normal BMI. Amongst the participants who had PE, 48 (66.67%) had normal BMI, 16 (22.22%) were overweight while 8 (11.11%) were obese. Majority of participants (66.67%) with probable/borderline PE had normal BMI, 16.67% were overweight while 16.67% were obese. P value of less than 0.05 was significant. Conclusion: This study shows that premature ejaculation is common amongst all age group and has a variable relationship with body habitus, possibly dependent on the sub-type of premature ejaculation. There was an inverse correlation between PE and BMI in younger populations which suggests a lifelong sub-type. PE was also commoner in leaner younger participants and the number of participants with PE decreased as BMI increased.
- 16 January 2025
- Published by Science Publishing Group in International Journal of Clinical Urology
- Vol. 9 (1) , 101-106
Open AccessPremature Ejaculation: Prevalence and Relationship with Body Mass Index
Introduction: Premature ejaculation is one of the major disorders of sexual functions in males. The prevalence rate of 25-40% has been reported across all age groups globally. Ejaculation latency is affected by psychosomatic factors which may include obesity but the relationship between PE and obesity have not been well documented in sub-Saharan Africa. This study evaluates the prevalence of PE and correlation between PE and body mass index. Methods: This is a prospective cross-sectional study carried out in Federal Capital Territory (FCT) Abuja, Nigeria over a period of 2 years from January 2019 to December 2020. By simple random sampling, participants were recruited for the study. Two questionnaires (a proforma and PEDT) were administered to all the participants who gave consent to be enrolled and met the inclusion criteria. Two basic anthropometric measurements (weight and height) were objectively obtained. Data obtained were analyzed using Statistical Package for Social Sciences version 20.0. P value of less than 0.05 was considered statistically significant. Results: A total of 426 persons participated in the study. Majority of the participants (51.88%) fell within the age range of 20-30 years, while seventy-five participants (17.61%) were between the age ranges of 31-40 years. Those that fell within the age range of 41-50, 51-60, and 61-70 years were 16.43%, 8.22% and 5.87% respectively. Seventy-two participants (16.9%) had PE while three hundred and six participants (71.83%) had no PE. Probable/borderline PE was noted in 48 (11.27%) participants. Mean age of participants with PE was 27.88 years while the mean age of participants with borderline PE was 25.67 years. Mean age of participants with no PE was 41.85 years. Sixty-seven participants (15.73%) were obese, 131 (30.75%) were overweight while 228 (53.52%) had normal BMI. Amongst the participants who had PE, 48 (66.67%) had normal BMI, 16 (22.22%) were overweight while 8 (11.11%) were obese. Majority of participants (66.67%) with probable/borderline PE had normal BMI, 16.67% were overweight while 16.67% were obese. P value of less than 0.05 was significant. Conclusion: This study shows that premature ejaculation is common amongst all age group and has a variable relationship with body habitus, possibly dependent on the sub-type of premature ejaculation. There was an inverse correlation between PE and BMI in younger populations which suggests a lifelong sub-type. PE was also commoner in leaner younger participants and the number of participants with PE decreased as BMI increased.
- Open Access
- 16 January 2025
- Published by Science Publishing Group in International Journal of Clinical Urology
- Vol. 9 (1) , 73-79
OuadMix Penile Injection: An Initial Urologists Experience
Introduction : QuadMix is considered to be one of the most powerful class of anti-erectile dysfunction agents and superior to all forms of intracavernosal injections especially in men with permanent/severe erectile dysfunction (ED) that has defiled oral therapy. QuadMix consists of papaverine HCl, phentolamine mesylate, prostaglandin E1 and atropine sulfate designed to act synergistically with satisfactory endpoint. We report our preliminary experience with QuadMIX in the management of permanent/severe ED. Methodology : This is a prospective study which was carried out between July 2020 to June 2022. Two questionnaires (a proforma and IIEF-5) were administered to all patients presenting with ED to objectively assess the etiology, risk factors and severity of ED without bias. Only patients who met the inclusion criteria were recruited for the study and informed consent was obtained. Individual test dose was calculated and the patients were subsequently trained on self-injection using an autoinjector. Two capsules of phenylephrine were also given to the patients to keep with them with appropriate instructions. Data obtained were analyzed using Statistical Package for Social Sciences version 20.0. P value of less than 0.005 was considered statistically significant. Results : Sixty patients were enrolled for the study. All patient had either permanent ED or severe ED. Thirty percent had radical prostatectomy surgery. Ten percent had trauma with pelvic bone involvement while 31.66%, 3.34% and 25% had comorbid conditions (diabetes mellitus and hypertension), prolonged priapism and no obvious organic etiology respectively. Forty percent of the patients failed to achieve satisfactory erection on oral medication while 60% had no erection despite taking phosphodiesterase type 5 inhibitors (PDE5i). All patients had tumescence for satisfactory sexual intercourse within 10 mins following administration of QuadMix. Fifty eight patients (96.67%) had spontaneous detumescence after ejaculation. Only 2 patients (3.34%) had priapism. One was reversed with ejaculation, use of ice pack around the perineum and caps phenylephrine while the second patient had intracavernosal aspiration to achieve detumescence. Conclusion : QuadMix is an effective and safe agent in the treatment of permanent and severe ED in patients with comorbid condition. It also improves quality of life (QoL) and sexual performance in patient who has had permanent ED following radical prostatectomy.
- 16 January 2025
- Published by Science Publishing Group in International Journal of Clinical Urology
- Vol. 9 (1) , 73-79
Open AccessOuadMix Penile Injection: An Initial Urologists Experience
Introduction : QuadMix is considered to be one of the most powerful class of anti-erectile dysfunction agents and superior to all forms of intracavernosal injections especially in men with permanent/severe erectile dysfunction (ED) that has defiled oral therapy. QuadMix consists of papaverine HCl, phentolamine mesylate, prostaglandin E1 and atropine sulfate designed to act synergistically with satisfactory endpoint. We report our preliminary experience with QuadMIX in the management of permanent/severe ED. Methodology : This is a prospective study which was carried out between July 2020 to June 2022. Two questionnaires (a proforma and IIEF-5) were administered to all patients presenting with ED to objectively assess the etiology, risk factors and severity of ED without bias. Only patients who met the inclusion criteria were recruited for the study and informed consent was obtained. Individual test dose was calculated and the patients were subsequently trained on self-injection using an autoinjector. Two capsules of phenylephrine were also given to the patients to keep with them with appropriate instructions. Data obtained were analyzed using Statistical Package for Social Sciences version 20.0. P value of less than 0.005 was considered statistically significant. Results : Sixty patients were enrolled for the study. All patient had either permanent ED or severe ED. Thirty percent had radical prostatectomy surgery. Ten percent had trauma with pelvic bone involvement while 31.66%, 3.34% and 25% had comorbid conditions (diabetes mellitus and hypertension), prolonged priapism and no obvious organic etiology respectively. Forty percent of the patients failed to achieve satisfactory erection on oral medication while 60% had no erection despite taking phosphodiesterase type 5 inhibitors (PDE5i). All patients had tumescence for satisfactory sexual intercourse within 10 mins following administration of QuadMix. Fifty eight patients (96.67%) had spontaneous detumescence after ejaculation. Only 2 patients (3.34%) had priapism. One was reversed with ejaculation, use of ice pack around the perineum and caps phenylephrine while the second patient had intracavernosal aspiration to achieve detumescence. Conclusion : QuadMix is an effective and safe agent in the treatment of permanent and severe ED in patients with comorbid condition. It also improves quality of life (QoL) and sexual performance in patient who has had permanent ED following radical prostatectomy.